Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas
This study has been terminated.
( Study terminated prematurely due to financial constraints. )
Study NCT00457574   Information provided by Gemin X

First Received on April 5, 2007.   Last Updated on September 14, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumors and Lymphomas
Additional conditions recognized in this trial
Lymphoma
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
GMX1777
Sponsors listed in this trial
Gemin X


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services